These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 216485)
1. Differences in the ability of human lymphoblastoid lines to exclude bromodeoxyuridine and in their sensitivity to methyl methanesulfonate and to incorporated [3H]thymidine. Higgins NP; Strauss BS Cancer Res; 1979 Feb; 39(2 Pt 1):312-20. PubMed ID: 216485 [TBL] [Abstract][Full Text] [Related]
2. Differences in the incorporation of bromodeoxyuridine by human lymphoblastoid cell lines. Henderson EE; Strauss B Cell; 1975 Aug; 5(4):381-7. PubMed ID: 1157096 [TBL] [Abstract][Full Text] [Related]
3. DNA excision-repair deficiency of human peripheral blood lymphocytes treated with chemical carcinogens. Scudiero D; Norin A; Karran P; Strauss B Cancer Res; 1976 Apr; 36(4):1397-403. PubMed ID: 1260764 [TBL] [Abstract][Full Text] [Related]
4. Induction of tubuloreticular inclusions in human lymphoma cells (Raji line) related to S-phase treatment with halogenated pyrimidines. Hulanicka B; Barry DW; Grimley PM Cancer Res; 1977 Jul; 37(7 Pt 1):2105-13. PubMed ID: 861937 [No Abstract] [Full Text] [Related]
6. Mutagenesis of Chinese hamster cells in vitro by combination treatments with methyl methanesulfonate and N-acetoxy-2-acetylaminofluorene. Myhr BC; DiPaolo JA Cancer Res; 1978 Aug; 38(8):2539-43. PubMed ID: 208770 [TBL] [Abstract][Full Text] [Related]
7. Reassociation of human lymphoblastoid cell DNA repair replicated following methyl methanesulfonate treatment. Meltz ML; Whittam NJ; Thornburg WH Chem Biol Interact; 1982 Mar; 39(1):77-88. PubMed ID: 7060222 [TBL] [Abstract][Full Text] [Related]
8. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Diddens H; Niethammer D; Jackson RC Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514 [TBL] [Abstract][Full Text] [Related]
9. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Masuda H; Ozols RF; Lai GM; Fojo A; Rothenberg M; Hamilton TC Cancer Res; 1988 Oct; 48(20):5713-6. PubMed ID: 3139281 [TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a mutant mouse lymphoma cell sensitive to methyl methanesulfonate and X rays. Sato K; Hieda N Radiat Res; 1979 Apr; 78(1):167-71. PubMed ID: 221956 [No Abstract] [Full Text] [Related]
11. Statistical confirmation that immunofluorescent detection of DNA repair in human fibroblasts by measurement of bromodeoxyuridine incorporation is stoichiometric and sensitive. Selden JR; Dolbeare F; Clair JH; Nichols WW; Miller JE; Kleemeyer KM; Hyland RJ; DeLuca JG Cytometry; 1993; 14(2):154-67. PubMed ID: 8440149 [TBL] [Abstract][Full Text] [Related]
13. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine. Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773 [TBL] [Abstract][Full Text] [Related]
14. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus. Blazar BA; Sutton LM; Strome M Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371 [TBL] [Abstract][Full Text] [Related]
15. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409 [TBL] [Abstract][Full Text] [Related]
16. Mutagen sensitivity in thymidine kinase- and methyltransferase-deficient human lymphoblastoid cells. Best CJ; McKenna PG; McKelvey-Martin VJ Br J Biomed Sci; 1997 Dec; 54(4):267-72. PubMed ID: 9624737 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a phenoxazine compound, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis, and necrosis. Koshibu-Koizumi J; Akazawa M; Iwamoto T; Takasaki M; Mizuno F; Kobayashi R; Abe A; Tomoda A; Hamatake M; Ishida R J Cancer Res Clin Oncol; 2002 Jul; 128(7):363-8. PubMed ID: 12136250 [TBL] [Abstract][Full Text] [Related]
18. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines. Steel CM; Morten JE; Foster E IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993 [TBL] [Abstract][Full Text] [Related]
19. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A; Pfaff P; Lange W; Finke J Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686 [TBL] [Abstract][Full Text] [Related]
20. [Supertransformation of a human lymphoblastoid cell line by chemical carcinogens]. Le François-Chabas D; Montagnier L C R Seances Acad Sci III; 1983; 296(6):283-6. PubMed ID: 6303529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]